Petition opposing the threatened closure of the Royal London Hospital service has attracted more than 34,000 signatures Campaigners say the specialist Royal London Hospital Sickle Cell Day Unit ...
Gilead Sciences' cell therapy unit Kite has reached an agreement to buy Interius BioTherapeutics, bolstering its efforts to develop therapies that do not require cells to be removed from the body ...
Bone-marrow-derived multipotent progenitor stromal cells — or mesenchymal stem cells (MSCs) — are the common predecessors of cells of the mesenchymal lineage, such as bone, cartilage and fat cells.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results